A custom-designed microarray slide has been designed for the analysis of gene expression in individuals with B-cell chronic lymphocytic leukaemia.

A DNA diagnostic testing service has been set up to quantify the effectiveness of biological control tools on cotton pest management.

Greenpeace has hired its first local team to campaign against genetic engineering in Australia. [ + ]

More attention needs to be paid to intellectual property, especially in Universities and institutions, is the message from Melbourne patent attorney Dr Neil Ireland. [ + ]

Gradipore is on the hunt for a global CEO and an independent chair in a bid to become a "multi-billion dollar organisation," executive chairman John Manusu said today. [ + ]

Ambri's Dr Bruce Cornell is the new addition to the NSW Innovation Council, after being appointed by the Treasurer and Minister for State Development, Michael Egan. [ + ]

Biomedical research projects in Singapore have landed $S62.6 million (nearly $AU64 million) in the first round of a new grant scheme launched by the island nation's Agency for Science, technology and Research (A*Star). [ + ]

Norwood Abbey today announced it was awaiting FDA approval for its newly patented laser drug delivery system for anaesthesia. [ + ]

Demand by drug discovery companies for carbohydrate chemistry specialist Alchemia's library of novel molecules is increasing. An agreement signed with US biotech CelTor BioSystems this week is the second collaborative pact Alchemia has announced in the past three weeks. [ + ]

Evisense, a Sydney University spin-off, holds the patents for some diagnostic devices that are potentially worth millions. The problem is that its inventor, Dr Richard Appleyard, is not able to work on developing his technologies. [ + ]

GroPep has sacked its managing director because of a difference of opinion over the company's direction. [ + ]

La Trobe University has recently opened a new research facility in the field of population biology on its main Melbourne campus.

Leading Queensland medical research centre QIMR has discovered that swapping intellectual property for shares has its downside. [ + ]

Perth-based Australian Cancer Technology has appointed Dr Roger Aston, former Peptech CEO, to Executive Chairman to oversee their joint ventures, with London-based drug discovery services company Biofocus, and other cancer therapy projects. [ + ]

IBM will provide the Mayo Clinic with database tools, permitting doctors at the famed hospital to compare notes with every other case the facility has on record, it announced today in a statement. Their goal is to make every doctor a research scientist. [ + ]